Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CryoCath Technologies

CryoCath Technologies?uq=gJQ7UQwH
1994 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
$295M LATEST DEAL AMOUNT
Description

Manufacturer and developer of medical devices. The company is engaged in the manufacture and sale of catheter-based cryotherapy technology. It develops products and methods for the delivery of cryoenergy. Its product include cardiac cryoablation catheter system intended for use in the treatment of heart tachyarrhythmias.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Acquirer
Primary Office
  • 16771 Chemin Ste-Marie
  • Montrea, Quebec H9H 5H3
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CryoCath Technologies’s full profile, request a free trial.

CryoCath Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Nov-2008 $295M 000.00 00000 Completed Profitable
3. IPO 31-Oct-2000 000.00 000.00 Completed Clinical Trials - General
2. Early Stage VC 03-Feb-1998 $10.2M $12.3M Completed Startup
1. Early Stage VC $2.07M $2.07M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CryoCath Technologies Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Crescendo Ventures Venture Capital Minority 000 0000 000000 0
French Government Government Minority 000 0000 000000 0
Robertson Stephens Investment Bank Minority 000 0000 000000 0
Sofinnova Venture Capital Minority 000 0000 000000 0

CryoCath Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Jan Keltjens Chief Executive Officer & President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »